China calls WTO ruling 'dangerous' in solar cell row with U.S.



(Removes repeated phrase in para 3)

GENEVA, Sept 27 (Reuters) - China lambasted a World Trade Organization (WTO) ruling in a row with the United States over Washington's measures to limit the import of solar panel cells, calling it "erroneous and dangerous" on Monday.

A WTO panel handed a victory to the United States earlier this month, rejecting all four of China's claims and saying the U.S. measures did not breach global trade rules. China said last week it would appeal the decision.

At the private meeting, China's delegate expressed "deep concern with the systematically harmful findings made by the panel report," according to a statement sent by the Chinese delegation.

"The erroneous and dangerous signal sent by this panel report to WTO members will lead to the abuse of safeguard measures and thus seriously undermine the rules-based multilateral trading system," it added, saying the ruling could encourage protectionism.

The United States imposed a system of tariffs and a quota in 2018 after U.S. producers complained that imports of certain crystalline silicon photovoltaic cells had increased to such an extent that U.S. domestic industry risked serious harm.

The "safeguard" measures are due to be in place for four years, with annual reductions in the duty rates from an initial 30%. The duties have applied to solar modules and, beyond a set quota, to solar cells.

China's appeal will have no immediate effect since the top WTO dispute settlement body does not have enough judges to function. That is because the administration of former U.S. President Donald Trump blocked judge appointments to the body and paralysed its functions.

"The United States is disappointed that China has now decided to press onward by appealing the Panel report in spite of overwhelming evidence of the damaging effects of China’s non-market practices...," the U.S. delegate said at the same meeting on Monday.
Reporting by Emma Farge

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.